Bone mineral density in late pregnancy: singleton versus twin gestations
Official title: Pregnancy-associated Reduction in Bone Mineral Density: a Comparative Study Using REMS Technology Between Singleton and Twin Pregnancies in the Third Trimester
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07508553 · Data updated 2026-11-12
This project tests whether women with twin pregnancies have different bone mineral density in the third trimester than women carrying one baby, using two questionnaires and REMS ultrasound densitometry.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 45 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Drugs / interventions | cart, radiation |
| Locations | 1 site (Roma, RM) |
| Status | Recruiting |
| Started | December 23, 2025 |
| Main results expected | December 23, 2026 |
| Study ends | December 23, 2027 |
| Registry record updated | April 2, 2026 |
| Trial ID | NCT07508553 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 30–45 with singleton or dichorionic/monochorionic twin pregnancies at 35–41 weeks gestation, BMI 18.5–34, without prior fractures or a diagnosis of osteopenia/osteoporosis, who can give consent and complete questionnaires.
✕Probably not a fit
Women outside the age or gestational windows, with diagnosed osteopenia/osteoporosis, current bone-affecting diseases, recent fractures, motor disabilities, or taking vitamin D or bone-active medications during pregnancy are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Women between 35 and 41 weeks of gestation will complete two Fragility Fracture Observatory (OFF) questionnaires covering dietary calcium intake, Mediterranean diet adherence (Predimed), and a fracture-risk algorithm (AFEF), and will undergo a radiation-free REMS bone densitometry exam. Clinical, obstetric, demographic, and anthropometric data including age, BMI, medical and medication history will be recorded at enrollment. The primary comparison is third-trimester BMD between singleton and dichorionic/monochorionic twin pregnancies, with secondary analyses relating BMD to questionnaire scores and maternal clinical factors. Results aim to clarify relationships between pregnancy type, maternal factors, and bone health near term.
Why it matters
Potential benefit: If successful, the findings could help identify pregnant women at higher risk of low bone density so clinicians can tailor monitoring and nutritional support during pregnancy and postpartum.
How similar studies have gone: REMS ultrasound densitometry is a relatively new, radiation-free method with some supportive data for peripartum bone assessment, but direct comparisons of third-trimester BMD between singleton and twin pregnancies are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA 1. Signed informed consent 2. Willingness to participate in the study and ability to complete the study questionnaires 3. Women between 35 and 41 weeks of gestational age at the time of study inclusion 4. Singleton or twin pregnancy (dichorionic or monochorionic) 5. Age between 30 and 45 years at the time of study recruitment 6. No history of recent or previous bone fractures or traumatic fractures, and no motor disabilities (in the mother). 7. Absence of a diagnosis of osteopenia or osteoporosis according to the criteria of the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). 8. No intake of vitamin D or other medications during pregnancy. 9. Absence of current or previous conditions that could potentially interfere with bone metabolism (e.g., thyroid, kidney, or liver disease). 10. Women of normal weight or with class I obesity (BMI between 18.5 and 34). EXCLUSION CRITERIA Patients will not be included in the study if at least one of the following exclusion criteria is met: 1. Failure to sign the informed consent form 2. Poor compliance and/or inability to complete the study questionnaires 3. Women with previous or newly diagnosed comorbidities during pregnancy 4. Age \<30 and \>45 years 5. Previous diagnosis of osteopenia or osteoporosis according to the criteria of the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) 6. BMI \<18.5 or \>34
Where it's running
-
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Rm, Italy Recruiting
Study contacts
- Principal investigator: Tullio Ghi — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study coordinator: Tullio Ghi
- Email: tullio.ghi@policlinicogemelli.it
- Phone: 0630155989
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Role of LH and hCG in adults being evaluated for endocrine disorders
This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.